Introduction
The potent plasma triglyceride-lowering effect of long chain polyunsaturated fatty acids of the n-3 type may offer the best dietary means for treating hypertriglyceridemia (1).
Patients with combined hyperlipoproteinemia may also benefit, with profound falls in plasma triglyceride but a more limited reduction in cholesterol, especially in LDL cholesterol (1). The potential of fish oil preparations, rich in n-3 fatty acids, for treating hypercholesterolemia has not been established.
Several studies of normolipidemic subjects have shown approximately equivalent LDL cholesterol levels with either n-6 or n-3 fatty acid-rich diets (2-4). The two types of polyunsaturated fatty acid-rich diets may therefore be equipotent in lowering cholesterol levels, at least with the dosages reported in those studies. A further question which deserves examination is the nature of the interaction between dietary cholesterol and dietary n-3 fatty acids. The magnitude of the rise in plasma cholesterol when cholesterol consumption increases is partly dependent on the amount and nature of the dietary fatty acids. Plasma cholesterol levels rise less as the proportion of n-6 fatty acids increases (5, 6). The present study is 752 aimed to determine whether dietary n-3 fatty acids can also modify the rise in plasma cholesterol which is inducible with dietary cholesterol.
Methods
Six healthy normolipidemic volunteers, aged 2 1-35, were studied.
All weighed between ±8% of ideal body weight and none had consumed alcohol immoderately. The subjects were hospital inpatients for the 7 wk duration of the study. Three dietary periods were undertaken: habitual diet (1 wk) followed by a fish oil enriched diet (3 wk) and concluding with a fish-oil cholesterol-supplemented diet (3 wk). Although the composition of the first diet was identical for all subjects, it was reasonably representative of the preadmission eating habits of the six men, estimated by interview. Egg albumen was also given during the low cholesterol period. The subjects were weighed daily and changes necessary to maintain constant weight were made during a brief runin period prior to the control diet.
Laboratory methods
Samples of blood were obtained after the subjects had fasted 12 h. Samplings were made on the last 2 days of the first diet, and on each of the last 3 days of periods 2 and 3. Plasma was separated into the following lipoprotein fractions:
1) large VLDL, (Sf> 60) obtained by ultracentrifugation for 2 h at 100,000 X g in a 50 (1-3).
In the present study, 40 g daily has achieved a comparable result and in further studies (unpublished), moderate lowering of plasma triglyceride has been induced with 15 g oil daily (5 g n-3 fatty acid).
While the effect on triglyceride metabolism is far greater than occurs with n-6 fatty acids which saturated fatty acids contributed 37% and n-6 fatty acids 18% of total fatty acids; (MaxEPA comprised 30% saturated fatty acid, 2% n-6 fatty acids, and 35% n-3 fatty acids). Harris et al (2) demonstrated similar LDL cholesterol lowering effects with salmon oil (3% n-6 and 20% n-3) and with safflower/corn oil (54% n-6 and <1% n-3 raised from 300 mg to 1050 mg the rise in LDL cholesterol on the most highly saturated fatty acid diet was 16 mg/dl compared to 9 mg/dl when the P/S ratio was 0.8 and 6 mg/ dl when it was 2.5 (6). Plasma apo-B concentrations however rose with cholesterol supplementation at all three P/S ratios. The present study suggests that an n-3 fatty acid enriched diet is also effective in suppressing the dietary cholesterol-induced rise in LDL cholesterol.
The P/S ratio in the present diet was 
